Pfizer Ploughs €90.5M Into French Co. For Lyme Vaccine
Pharmaceutical giant Pfizer plans to invest €90.5 million ($95 million) in vaccine company Valneva to allow them to continue their collaboration on a program for Lyme disease, the firms said....To view the full article, register now.
Already a subscriber? Click here to view full article